At Propedix, we’re redefining the treatment of skin conditions and infections through breakthrough formulations and innovative delivery systems. Our mission is to meet unmet patient needs with science-backed, clinically proven solutions designed for real-world effectiveness. From over-the-counter remedies to advanced therapeutic options, we’re committed to transforming how dermatological and infectious conditions are treated—safely, effectively, and accessibly.
Propedix brings exceptional expertise in developing advanced topical dermatology formulations.
Our team has been instrumental in the R&D, formulation, and commercialization of renowned products such as Tazorac, Bellafill, Juvéderm, SkinPen, Zoryve and Aczone among others. Leveraging a proprietary technology platform, Propedix enhances the activation of traditional active ingredients, ensuring more effective delivery and improved compliance in topical treatments.
Meet our Leading Team of accomplished executives with a passion for innovating in healthcare.
Board Director
KPMG, Deloitte and Touche, Katalyst Surgical, Kogent Surgical
CPA, B.S. San Diego State
Chief Executive Officer
Chief Executive Officer
Founder, Chief Medical Officer
Chief Commercial Officer
Chief Technology Officer
Controller
R&D, Scientific Advisory Board
R&D, Scientific Advisory Board
Dr. Louis Kuchnir founded Kuchnir Dermatology in 2001 where he and colleagues care for a thousand patents weekly. He served as president of the Massachusetts Academy of Dermatology from 2009-2015. He received his medical degree from Washington University in St. Louis. He earned a PhD in physical chemistry at Harvard University and went to college at MIT. He is board-certified by the American Board of Dermatology.
R&D, Scientific Advisory Board
Adam M. Rotunda, M.D. is a double board-certified dermatologist with specialized training in Mohs micrographic and reconstructive surgery. A Fellow of the American Academy of Dermatology and a fellowship-trained member of the American College of Mohs Surgery, Dr. Rotunda focuses exclusively on skin cancer removal and complex reconstruction at his practice in Newport Beach, California.
R&D, Scientific Advisory Board
Thanh-Nga Tran, MD, PhD, graduated from Caltech with a BS in Chemical Engineering before pursuing both her MD and PhD through the Harvard-MIT Health Sciences and Technology program at Harvard Medical School. She completed her doctoral research under Dr. Robert Langer at MIT, focusing on drug delivery and nanotechnology.
Dr. Tran trained in dermatology at the Harvard Combined Dermatology Residency Program and subsequently completed a postdoctoral fellowship with Dr. David Fisher at Massachusetts General Hospital. Her research bridges biomedical engineering, nanotechnology, laser medicine, and drug delivery, with the goal of developing innovative therapies for dermatologic conditions.
20 Park Plaza Boston, MA 02116, USA
California Office – coming soon
